177 related articles for article (PubMed ID: 19724988)
21. Pediatric Musculoskeletal Imaging: The Indications for and Applications of PET/Computed Tomography.
Khalatbari H; Parisi MT; Kwatra N; Harrison DJ; Shulkin BL
PET Clin; 2019 Jan; 14(1):145-174. PubMed ID: 30420216
[TBL] [Abstract][Full Text] [Related]
22. Contributions of nuclear medicine in paediatric non-tumour musculoskeletal pathology.
Noriega-Álvarez E; Orduña Diez MDP; Domínguez Gadea L; Sanz Viedma S; Loza SM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(3):188-201. PubMed ID: 33824088
[TBL] [Abstract][Full Text] [Related]
23. PET/CT in malignant bone disease.
Even-Sapir E
Semin Musculoskelet Radiol; 2007 Dec; 11(4):312-21. PubMed ID: 18324596
[TBL] [Abstract][Full Text] [Related]
24. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT.
Gnanasegaran G; Cook G; Adamson K; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):380-95. PubMed ID: 19801218
[TBL] [Abstract][Full Text] [Related]
25. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
[TBL] [Abstract][Full Text] [Related]
26. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
27. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
28. Musculoskeletal pitfalls in 18F-FDG PET/CT: self-assessment module.
Costelloe CM; Murphy WA; Chasen BA
AJR Am J Roentgenol; 2009 Sep; 193(3 Suppl):S26-30. PubMed ID: 19696241
[TBL] [Abstract][Full Text] [Related]
29. PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Choi YY; Kim JY; Yang SO
Semin Musculoskelet Radiol; 2014 Apr; 18(2):133-48. PubMed ID: 24715446
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
Demura Y; Tsuchida T; Ishizaki T; Mizuno S; Totani Y; Ameshima S; Miyamori I; Sasaki M; Yonekura Y
J Nucl Med; 2003 Apr; 44(4):540-8. PubMed ID: 12679397
[TBL] [Abstract][Full Text] [Related]
31. Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT.
Goerres GW; Schmid DT; Schuknecht B; Eyrich GK
Radiology; 2005 Oct; 237(1):281-7. PubMed ID: 16118155
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in hybrid molecular imaging systems.
Lee JS; Kim JH
Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
[TBL] [Abstract][Full Text] [Related]
33. Pediatric bone scintigraphy update.
Nadel HR
Semin Nucl Med; 2010 Jan; 40(1):31-40. PubMed ID: 19958848
[TBL] [Abstract][Full Text] [Related]
34. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties.
Van Acker F; Nuyts J; Maes A; Vanquickenborne B; Stuyck J; Bellemans J; Vleugels S; Bormans G; Mortelmans L
Eur J Nucl Med; 2001 Oct; 28(10):1496-504. PubMed ID: 11685492
[TBL] [Abstract][Full Text] [Related]
36. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
37. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
38. Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors.
Cook GJ; Gnanasegaran G; Chua S
Semin Nucl Med; 2010 Jan; 40(1):52-61. PubMed ID: 19958850
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
40. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
